GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Role of HOS in Cell Transformation and Apoptosis

$247,041
Serge Y Fuchs · University Of Pennsylvania · R01 · FY2014 · CA

Tumor-Selective Oncolytic Vaccinia Virus and alphaDC1-Based Vaccine as a Combinat

$247,021
David L Bartlett · University Of Pittsburgh At Pittsburgh · P01 · FY2010 · CA

Defining a Stromal Signature that Facilitates Progression of Lethal Cancers

$247,013
Philippe D Gascard · University Of California, San Francisco · R50 · FY2020 · CA

Defining a Stromal Signature that Facilitates Progression of Lethal Cancers

$247,013
Philippe D Gascard · University Of California, San Francisco · R50 · FY2023 · CA

Defining a Stromal Signature that Facilitates Progression of Lethal Cancers

$247,013
Philippe D Gascard · University Of California, San Francisco · R50 · FY2022 · CA

Impact of Neutrophil Extracellular Traps (NETs) on the Pancreatic Tumor Microenvironment

$246,840
Brian A Boone · West Virginia University · P20 · FY2021 · GM

Circulating HSP70 in Hyperthermia and Cancer Therapy

$246,820
Alexzander A Asea · Scott And White Memorial Hospital · R01 · FY2006 · CA

Molecular Pathology and Genomics Core

$246,787
Jon C Aster · Dana-Farber Cancer Inst · P01 · FY2022 · CA

Cell Migration Control through Modulation of Multiple Directional Cues

$246,767
Ian Christopher Schneider · Iowa State University · R01 · FY2024 · GM

Delineating the myeloid-centric immunosuppressive crosstalk as targets for prognosis and therapy in neuroendocrine tumors

$246,752
Christopher M Heaphy · Boston Medical Center · R21 · FY2025 · CA

Impact of Neutrophil Extracellular Traps (NETs) on the Pancreatic Tumor Microenvironment

$246,714
Brian A Boone · West Virginia University · P20 · FY2022 · GM

Inducing Tumor Neoantigens Through RNA Editing for Cancer Immunotherapy

$246,711
Jeffrey A. Hubbell · University Of Chicago · R21 · FY2023 · CA

Mechanistic Determination of KRAS Lung Cancer Regression upon CRAF Suppression

$246,690
Victoria Wang · University Of California, San Francisco · K08 · FY2024 · CA

Mechanistic Determination of KRAS Lung Cancer Regression upon CRAF Suppression

$246,690
Victoria Wang · University Of California, San Francisco · K08 · FY2025 · CA

Mechanistic Determination of KRAS Lung Cancer Regression upon CRAF Suppression

$246,690
Victoria Wang · University Of California, San Francisco · K08 · FY2022 · CA

Mechanistic Determination of KRAS Lung Cancer Regression upon CRAF Suppression

$246,690
Victoria Wang · University Of California, San Francisco · K08 · FY2023 · CA

Mechanistic Determination of KRAS Lung Cancer Regression upon CRAF Suppression

$246,690
Victoria Wang · University Of California, San Francisco · K08 · FY2020 · CA

Prometastatic Effects of Neoadjuvant Chemotherapy in Breast Cancer

$246,673
George S Karagiannis · Albert Einstein College Of Medicine · R00 · FY2023 · CA

STROMELYSIN 3 AND THE TUMOR MICROENVIRONMENT

$246,645
Dana-Farber Cancer Institute · R01 · FY2001 · CA

Mechanisms of Sensitivity and Resistance to the Kinase Inhibitor Cabozantinib in Castrate Resistant Prostate Cancer

$246,637
Evan Todd Keller · University Of Michigan At Ann Arbor · P50 · FY2016 · CA

Project 3: Role of the pancreatic fibroinflammatory microenvironment in obesity-promoted pancreatic cancer

$246,612
Stephen J Pandol · University Of California Los Angeles · P01 · FY2023 · CA

In-situ activation of antitumor effectors

$246,522
Edmund C. Lattime · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2012 · CA

Defining mechanisms of cancer chemoresistance and metastasis

$246,504
Swarnali Acharyya · Columbia University Health Sciences · R00 · FY2016 · CA

Metabolic regulation of FOLFIRINOX acquired resistance in pancreatic cancer

$246,500
Pankaj Kumar Singh · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2023 · CA

Low-Fat/Fish Oil Diet and prostate Cancer Outcomes in Human Cohorts and Mouse Mo

$246,421
William J Aronson · University Of California Los Angeles · P50 · FY2014 · CA